Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Physicians who Perform Dialysis

Articles with lock require a subscription to GLG News | Request a free trial
August 4, 2008
FDA Restrictions on ESA's Will Have Minimal Effect of EPO Usage.
Analysis of: Amgen Told to Reword Drug Label | www.nytimes.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
1)  Concerns over the new FDA restrictions on ESA's is being overstated. 2)  Amgen will continue to do well in the ESA market place, in spite of these changes. 3)  J&J will receive the brunt of these changes, strictly because of their market concentration in the oncology market. 4) ...
August 4, 2008
Veterans Admininstration Sets The Standard for Electronic Medical Records: Why Re-invent The Wheel?
Analysis of: Nationwide EHR Implementation Price Tag Estimated at $150 billion | www.govhealthit.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
The VA has already won many awards for an electronic medical records system, which tax payers have already paid for. Adopting the VA "CPRS" program would save the taxpayers and the private sector hundreds of billions of dollars.
Richard AmerlingJuly 25, 2008
The Dark Side of Fosamax
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: Richard Amerling, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INC
Considering the effects of fosamax and other bisphosphonates on bone remodeling, it is not at all surprising to see problems arising with the long term use of these agents.  
Richard AmerlingJuly 10, 2008
So Much for Health "Insurance"
Analysis of: Pricey Drugs Put Squeeze on Doctors | online.wsj.com
Author: Richard Amerling, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INC
It's intresting that nowhere in this article was the topic of true insurance for catastrophic illness brought up.  The problem with our current health insurance market is that for most it is pre-paid care, not insurance against a rare, but catastrophic, event. 
Richard AmerlingJuly 10, 2008
Our Kids on Statins...........Not!
Analysis of: 8-Year-Olds on Statins? A New Plan Quickly Bites Back | www.nytimes.com
Author: Richard Amerling, Director of Outpatient Dialysis, BETH ISRAEL MEDICAL CENTER INC
With the pipeline for new drugs running dry, it is no surprise that pharmaceutical companies are looking to expand indications for existing products still under patent protection.  What better way to do this than by creating entirely new patient populations out of whole cloth?
May 27, 2008
Tekturan losers blood pressure and proteinuria simultaneously
Analysis of: New data show Tekturna HCT® is twice as effective at reducing blood pressure than the diuretic HCT alone | www.novartis.com
Author: Jack Rubin, Medical Director, Davita Los Angeles Dialysis Center
While no more would argue that control of systolic hypertension is crucial to preventing the consequences of hypertension such as congestive heart failure, MI's, left ventricular hyperthrophy, stroke and kidney failure there are other factors that are associated with these disease states. One of these...
April 30, 2008
FDA: Chinese Manufacturer of Tainted Heparin Involved in Fraud.
Analysis of: UPDATE: FDA Head Sees Economic Fraud Behind Tainted Heparin | www.reuters.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
First, and foremost, the only working link for this article can be found at: http://www.reuters.com/article/domesticNews/idUSWAT00934620080415?feedType=RSS&feedName=domesticNews Although there is no proof offered in the article to substantiate the suggestion of fraud, there is enough circumstantial...
April 30, 2008
FDA Fees Must Be Increased to Fund Inspection of Chinese Products.
Analysis of: FDA fees eyed to boost food, drug safety | www.usatoday.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
One only has to read about the Heparin debacle, which has killed, at least, 81 Americans, to realize that there is a serious issue with the quality of medicines produced in China.  Manufacturing of medical food and consumer goods in China is growing at such a rate, the Chinese government has neither...
April 30, 2008
Who to Blame for Waste in the Medical Industry? Who's on First?
Analysis of: The Price of Excess: Identifying Waste in Healthcare Spending | blogs.wsj.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
It's easy to point fingers of blame and this article does that, very well.  According to the "annalysis" everybody is to blame.  And, they're right, everyone is to blame, but where the article fails is the authoris inability to point out a real solution to the problem of wasted dollars spent...
April 30, 2008
Anemia Drugs Have Been Abused for Profit!
Analysis of: WellPoint likely to follow FDA on anemia drugs | www.reuters.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
Over the last year, it has become clear that the over-use of anemia drugs for cancer and renal failure has become a problem.  The reason can be sumed up in one word, which is profit.

Page : 1 2 Next1 to 10 of 16

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T01:45:24.617